Tag Archives: ZGNX

Zogenix (ZGNX) Receives a Buy from Needham

In a report released today, Serge Belanger from Needham maintained a Buy rating on Zogenix (ZGNX – Research Report), with a price target of $58.00. The company’s shares closed last Monday at $47.11. According to TipRanks.com, Belanger is a 3-star

Zogenix (ZGNX) Receives a Buy from Mizuho Securities

Mizuho Securities analyst Difei Yang maintained a Buy rating on Zogenix (ZGNX – Research Report) today and set a price target of $65.00. The company’s shares closed last Monday at $46.83. According to TipRanks.com, Yang ‘s ranking currently consits of

Monday’s Midday Movers: Clovis Oncology (CLVS), Arrowhead Research (ARWR), Splunk (SPLK), Exact Sciences (EXAS), Zogenix (ZGNX)

So far Monday, November 25, NASDAQ is up 2.64% and the S&P is up 0.83%. Here are this morning’s most active stocks: Clovis Oncology (CLVS – Research Report), Arrowhead Research (ARWR – Research Report), Splunk (SPLK – Research Report), Exact

Analysts Offer Insights on Healthcare Companies: Zogenix (NASDAQ: ZGNX) and Aslan Pharmaceuticals (NASDAQ: ASLN)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Zogenix (ZGNX – Research Report) and Aslan Pharmaceuticals (ASLN – Research Report) with bullish sentiments. Zogenix (ZGNX) In a report released today,

Zogenix (ZGNX) Gets a Buy Rating from Mizuho Securities

Mizuho Securities analyst Difei Yang maintained a Buy rating on Zogenix (ZGNX – Research Report) today and set a price target of $65.00. The company’s shares closed last Monday at $42.41. According to TipRanks.com, Yang is a 3-star analyst with

Wednesday’s Midday Stock Update: Merrimack Pharmaceuticals (MACK), Rite Aid Corp (RAD), Novavax (NVAX), La Jolla Pharma (LJPC), Zogenix (ZGNX)

So far Wednesday, September 11, NASDAQ is up 2.75% and the S&P is up 1.33%. Here are this morning’s most active stocks: Merrimack Pharmaceuticals (MACK – Research Report), Rite Aid Corp (RAD – Research Report), Novavax (NVAX – Research Report),